IRIS Accounts Production v25.1.3.33 Other Company accounts True false Pounds 1.1.24 31.12.24 31.12.24 FY FRS 102 Independent examiner Small companies regime for accounts Full Charities SORP true true true true false true false true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6707182023-12-31SC6707182024-12-31SC6707182024-01-012024-12-31SC6707182022-12-31SC6707182023-01-012023-12-31SC6707182023-12-31SC670718ns0:CharitableCompanyLimitedByGuarantee2024-01-012024-12-31SC670718ns15:PoundSterling2024-01-012024-12-31SC670718ns11:FRS1022024-01-012024-12-31SC670718ns11:IndependentExaminationCharity2024-01-012024-12-31SC670718ns11:SmallCompaniesRegimeForAccounts2024-01-012024-12-31SC670718ns11:FullAccounts2024-01-012024-12-31SC670718ns11:CharitiesSORP2024-01-012024-12-31SC670718ns16:EnglandWales2024-01-012024-12-31SC670718ns11:RegisteredOffice2024-01-012024-12-31SC670718ns0:Trustee22024-01-012024-12-31SC670718ns0:Trustee32024-01-012024-12-31SC670718ns0:Trustee12024-01-012024-12-31SC670718ns0:Trustee42024-01-012024-12-31SC670718ns0:Trustee52024-01-012024-12-31SC670718ns0:Trustee62024-01-012024-12-31SC670718ns0:Trustee72024-01-012024-12-31SC670718ns0:Trustee82024-01-012024-12-31SC670718ns0:Trustee92024-01-012024-12-31SC670718ns11:CompanySecretary12024-01-012024-12-31SC670718ns0:TotalUnrestrictedFunds2024-01-012024-12-31SC670718ns0:TotalRestrictedIncomeFunds2024-01-012024-12-31SC670718ns0:Activity82024-01-012024-12-31SC670718ns0:TotalUnrestrictedFundsns0:Activity82024-01-012024-12-31SC670718ns0:Activity8ns0:TotalRestrictedIncomeFunds2024-01-012024-12-31SC670718ns0:Activity82023-01-012023-12-31SC670718ns0:TotalUnrestrictedFunds2023-12-31SC670718ns0:TotalRestrictedIncomeFunds2023-12-31SC670718ns0:TotalUnrestrictedFunds2024-12-31SC670718ns0:TotalRestrictedIncomeFunds2024-12-31SC670718ns0:TotalUnrestrictedFundsns10:WithinOneYear2024-12-31SC670718ns10:WithinOneYearns0:TotalRestrictedIncomeFunds2024-12-31SC670718ns10:WithinOneYear2024-12-31SC670718ns10:WithinOneYear2023-12-31SC670718ns10:ComputerEquipment2024-01-012024-12-31SC67071822024-01-012024-12-31SC67071812024-01-012024-12-31SC67071812023-01-012023-12-31SC670718ns10:OwnedAssets2024-01-012024-12-31SC670718ns10:OwnedAssets2023-01-012023-12-31SC670718ns0:TotalUnrestrictedFunds2023-01-012023-12-31SC670718ns0:TotalRestrictedIncomeFunds2023-01-012023-12-31SC670718ns0:TotalUnrestrictedFundsns0:Activity82023-01-012023-12-31SC670718ns0:Activity8ns0:TotalRestrictedIncomeFunds2023-01-012023-12-31SC670718ns10:ComputerEquipment2023-12-31SC670718ns10:ComputerEquipment2024-12-31SC670718ns10:ComputerEquipment2023-12-31
REGISTERED COMPANY NUMBER: SC670718 (Scotland)
REGISTERED CHARITY NUMBER: 051187














Report of the Trustees and

Unaudited Financial Statements for the Year Ended 31 December 2024

for

Cancer Card
(A Company Limited by Guarantee)

Cancer Card






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Report of the Trustees 1 to 3

Independent Examiner's Report 4

Statement of Financial Activities 5

Balance Sheet 6 to 7

Notes to the Financial Statements 8 to 14

Cancer Card (Registered number: SC670718)

Report of the Trustees
for the Year Ended 31 December 2024


The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

Cancer Card Annual Report 2024

As Chair of Cancer Card, I am pleased to present our annual report for the year ended 31 December 2024, which reflects both our continued commitment to supporting those affected by cancer and the challenges we navigate in an evolving charitable landscape.

OBJECTIVES AND ACTIVITIES
Key Achievements in 2024
Enhanced Support Services: The substantial increase in our charitable activities expenditure demonstrates our commitment to expanding direct support. Our comfort boxes programme provided practical and emotional support across all 32 Scottish council areas.

Strong Financial Performance: We maintained a healthy balance between donations and fundraising activities, reducing over-reliance on any single income source. Our fundraising events show strong community engagement despite challenging economic conditions. This success in fundraising is particularly noteworthy given the widely acknowledged tough environment for charities in 2024.

Grant Success and Partnership Development: We secured grants from diverse funders, demonstrating strong confidence in our mission and approach. Our established partnerships with the National Lottery Community Fund and Pink Ribbon Foundation continued, providing stability and ongoing validation of our work.

The support from new funders was particularly encouraging, as they recognised our unique value proposition. Corporate interest in our services is clearly growing, evidenced by backing from Ventient Glenkerie Wind Farm and Bauer Radio. Meanwhile, charitable foundations including the HFD Charitable Trust, Wood Foundation and Allied Vehicles Trust joined other new supporters to significantly increase our overall funding base. This diversification across statutory, charitable trust and corporate funders strengthens our funding resilience while demonstrating growing recognition of Cancer Card's distinctive role in Scotland's cancer support landscape.

Operational Efficiency: Our cost management remained disciplined with fundraising costs representing just 24% of total expenditure, ensuring the majority of resources reach beneficiaries directly. Staff costs increased appropriately as we strengthened our professional service delivery capability.

ACHIEVEMENT AND PERFORMANCE
Governance and Leadership
The year concluded with a stable board structure, positioning us well for the governance transitions that would follow in early 2025 with the appointment of new trustees bringing fresh perspectives and expertise.

Strategic Focus
Our investment in digital infrastructure allocated to software and website development, positions Cancer Card to meet evolving needs in how people access support services. The growth in our Online Cancer Support Hub reflects this strategic priority.

The increase in staff costs to demonstrates our commitment to professional service delivery while maintaining our volunteer-supported model, which remains central to our community-focused approach.


Cancer Card (Registered number: SC670718)

Report of the Trustees
for the Year Ended 31 December 2024


ACHIEVEMENT AND PERFORMANCE
Looking Forward
As we move into 2025, Cancer Card's position as Scotland's only comprehensive cancer navigation service provides a strong foundation for continued growth. With proven impact demonstrated through our 1,000+ comfort box deliveries, 42,000 annual website users and exclusive partnerships, we are well-positioned to expand our reach.

Our financial stability, combined with the recognition that true demand is estimated at five times our current capacity based on Scotland's 36,000 annual cancer diagnoses, presents both opportunity and responsibility. We are committed to extending our helpline hours beyond the current 15 hours per week and developing comprehensive community resources across Scotland through proactive local partnerships.

The ongoing challenge of reaching underserved communities - particularly those in rural areas, digitally excluded individuals and those unaware that support exists - remains central to our strategic focus for the coming year.

Acknowledgements
I extend sincere thanks to our dedicated staff, volunteers, trustees and supporters whose combined efforts make our work possible. Special recognition goes to our grant funders, individual donors and fundraising participants who provide the resources enabling our continued service.

Cancer Card enters 2025 with optimism, financial strength and ongoing commitment to supporting those whose lives are affected by cancer.

FINANCIAL REVIEW
Financial Overview
The year delivered solid financial performance with total income of £191,636, representing a modest increase from the previous year's £189,448. This stability in our income streams demonstrates the continued trust and support from our donors, grant funders and the communities we serve.

Our expenditure rose by 21% as we expanded our charitable activities, particularly through our Online Cancer Support Hub. This investment reflects our strategic focus on enhancing digital support services for cancer patients and their families.

We closed the year with a surplus of £7,992, bringing our total reserves to £81,864. This prudent financial management ensures Cancer Card remains sustainable while maximising our impact for beneficiaries.

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Cancer Card is a company limited by guarantee, governed by its memorandum and articles of association and recognised as a charity by the Office of the Scottish Charity Regulator in accordance with the provisions of the Charities and Trustee Investments (Scotland) Act 2006. In accordance with the Memorandum of Association, every member is liable to contribute a sum of £1 in the event of the company being wound up.

Directors and members
The directors of the charitable company ("the charity") are also the trustees of the charity for the purposes of the Companies Act 2005, and throughout this report are collectively referred to as Directors.

The directors have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

Directors' induction and training
All new Directors are given a full induction which gives a background to the organisation, how it operates and an understanding of the impact that a diagnosis of cancer has on patients and their families. This includes briefing on the support services provided by Cancer Card.


Cancer Card (Registered number: SC670718)

Report of the Trustees
for the Year Ended 31 December 2024


STRUCTURE, GOVERNANCE AND MANAGEMENT
Principal Risks and Uncertainties
Cancer Card has a comprehensive risk management process in place. The Board of Directors has assessed the major risks to which the charity is exposed, in particular those related to the operations and services of the charity and are satisfied that systems are in place to mitigate the charity's exposure to major risks.

This review continues to identify that the on-going general economic downturn and the increased cost of living, Cancer Card's major financial risk relates to challenges in ensuring that income generation supports the cost of Cancer Card's charitable activities.

Reserves Policy
The Directors have looked at the requirements for reserves in light of the main risks to Cancer Card. The policy has recently been reviewed and revised and the agreed policy is to hold a minimum of three months expenditure in reserves.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
SC670718 (Scotland)

Registered Charity number
051187

Registered office
13-15 Morningside Drive
Edinburgh
EH10 5LZ

Trustees
Ms J A Hardy (Chair until 18.12.2023)
Ms K A Macartney
I Pirrie (appointed 24.3.25)
Ms E Hall
C Watson
E Fleming
Ms G Scholefield (resigned 5.7.24)
Ms K Frankish (appointed 8.5.25)
E Smith (appointed 1.3.25)

Company Secretary
I Pirrie

Independent Examiner
J S Accounting Services Limited
13-15 Morningside Drive
EDINBURGH
EH10 5LZ

Approved by order of the board of trustees on 25 September 2025 and signed on its behalf by:





I Pirrie - Trustee

Independent Examiner's Report to the Trustees of
Cancer Card

I report on the accounts for the year ended 31 December 2024 set out on pages five to fourteen.

Respective responsibilities of trustees and examiner
The charity's trustees are responsible for the preparation of the accounts in accordance with the terms of the Charities and Trustee Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006 (as amended). The charity's trustees consider that the audit requirement of Regulation 10(1)(a) to (c) of the Accounts Regulations does not apply. It is my responsibility to examine the accounts as required under Section 44(1)(c) of the Act and to state whether particular matters have come to my attention.

Basis of the independent examiner's report
My examination was carried out in accordance with Regulation 11 of the Charities Accounts (Scotland) Regulations 2006. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently I do not express an audit opinion on the view given by the accounts.

Independent examiner's statement
In connection with my examination, no matter has come to my attention :

(1) which gives me reasonable cause to believe that, in any material respect, the requirements

- to keep accounting records in accordance with Section 44(1)(a) of the 2005 Act and Regulation 4 of the 2006 Accounts Regulations; and
- to prepare accounts which accord with the accounting records and to comply with Regulation 8 of the 2006 Accounts Regulations

have not been met; or

(2) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.








June Sinclair CA
The Institute of Chartered Accountants of Scotland

J S Accounting Services Limited
13-15 Morningside Drive
EDINBURGH
EH10 5LZ

25 September 2025

Cancer Card

Statement of Financial Activities
for the Year Ended 31 December 2024

31.12.24 31.12.23
Unrestricted Restricted Total Total
fund funds funds funds
Notes £    £    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 2 99,538 42,984 142,522 144,332

Other trading activities 3 49,114 - 49,114 45,116
Total 148,652 42,984 191,636 189,448

EXPENDITURE ON
Raising funds 44,184 - 44,184 44,170

Charitable activities
Online Cancer Support Hub 94,154 45,306 139,460 108,039
Total 138,338 45,306 183,644 152,209

NET INCOME/(EXPENDITURE) 10,314 (2,322 ) 7,992 37,239


RECONCILIATION OF FUNDS
Total funds brought forward 59,022 14,850 73,872 36,633

TOTAL FUNDS CARRIED FORWARD 69,336 12,528 81,864 73,872

Cancer Card (Registered number: SC670718)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Unrestricted Restricted Total Total
fund funds funds funds
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 8 1,873 - 1,873 3,082

CURRENT ASSETS
Debtors 9 3,135 - 3,135 6,735
Cash at bank 65,488 24,767 90,255 74,330
68,623 24,767 93,390 81,065

CREDITORS
Amounts falling due within one year 10 (1,160 ) (12,239 ) (13,399 ) (10,275 )

NET CURRENT ASSETS 67,463 12,528 79,991 70,790

TOTAL ASSETS LESS CURRENT
LIABILITIES

69,336

12,528

81,864

73,872

NET ASSETS 69,336 12,528 81,864 73,872
FUNDS 11
Unrestricted funds 69,336 59,022
Restricted funds 12,528 14,850
TOTAL FUNDS 81,864 73,872

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


Cancer Card (Registered number: SC670718)

Balance Sheet - continued
31 December 2024

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 25 September 2025 and were signed on its behalf by:





I Pirrie - Trustee

Cancer Card

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.


Computer equipment - 25% on cost

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits
The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.


Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. DONATIONS AND LEGACIES
31.12.24 31.12.23
£    £   
Donations 85,369 83,507
Gift aid 6,669 5,852
Grants 50,484 54,973
142,522 144,332

Grants received, included in the above, are as follows:

31.12.24 31.12.23
£    £   
National Lottery Community Fund 9,454 9,848
Pink Ribbon Foundation 6,000 6,000
Tesco - 1,125
Peoples Postcode Lottery - 20,000
St James Place - 2,500
Robertson Trust - 8,000
AABie 1,500 2,500
Lanarkshire Wind Farm - 5,000
Wood Foundation 2,500 -
BM Murray - Books from Kevin 2,000 -
Penicuik High School 500 -
HFD Charitable Trust 3,000 -
Ventient Glenkerie Wind Farm 11,030 -
Allied Vehicles Trust 2,500 -
Bauer Radio 10,000 -
Mitchells Robertson 1,000 -
Balfour and Manson 1,000 -
50,484 54,973

3. OTHER TRADING ACTIVITIES
31.12.24 31.12.23
£    £   
Fundraising events 48,554 44,216
Shop income 560 -
Listing fees - 900
49,114 45,116


Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

4. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

31.12.24 31.12.23
£    £   
Depreciation - owned assets 1,209 1,210

5. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2024 nor for the year ended 31 December 2023.


The trustees are not remunerated for their duties as trustees.

Trustees' expenses

There was £154 paid in respect of trustees expenses in the year ended 31 December 2024 (2023 - £240).

6. STAFF COSTS

The average monthly number of employees during the year was as follows:

31.12.24 31.12.23
Admin and project staff 5 5

No employees received emoluments in excess of £60,000.

7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted Total
fund funds funds
£    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 112,984 31,348 144,332

Other trading activities 45,116 - 45,116
Total 158,100 31,348 189,448

EXPENDITURE ON
Raising funds 44,170 - 44,170

Charitable activities
Online Cancer Support Hub 86,532 21,507 108,039
Total 130,702 21,507 152,209

NET INCOME 27,398 9,841 37,239


RECONCILIATION OF FUNDS
Total funds brought forward 31,624 5,009 36,633


Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted Restricted Total
fund funds funds
£    £    £   
TOTAL FUNDS CARRIED FORWARD 59,022 14,850 73,872

8. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2024 and 31 December 2024 4,837
DEPRECIATION
At 1 January 2024 1,755
Charge for year 1,209
At 31 December 2024 2,964
NET BOOK VALUE
At 31 December 2024 1,873
At 31 December 2023 3,082

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Other debtors 3,075 6,675
Tax 60 60
3,135 6,735

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors - 1,561
Other creditors 139 71
Accruals and deferred income 12,240 5,693
Accrued expenses 1,020 2,950
13,399 10,275


Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

11. MOVEMENT IN FUNDS
Net
movement At
At 1.1.24 in funds 31.12.24
£    £    £   
Unrestricted funds
General fund 59,022 10,314 69,336

Restricted funds
Support delivery 576 - 576
Breast Cancer Journey 3,814 (1,020 ) 2,794
Comfort boxes 10,460 (1,302 ) 9,158
14,850 (2,322 ) 12,528
TOTAL FUNDS 73,872 7,992 81,864

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 148,652 (138,338 ) 10,314

Restricted funds
Support delivery 9,454 (9,454 ) -
Breast Cancer Journey 6,000 (7,020 ) (1,020 )
Comfort boxes 27,530 (28,832 ) (1,302 )
42,984 (45,306 ) (2,322 )
TOTAL FUNDS 191,636 (183,644 ) 7,992


Comparatives for movement in funds

Net
movement At
At 1.1.23 in funds 31.12.23
£    £    £   
Unrestricted funds
General fund 31,624 27,398 59,022

Restricted funds
Support delivery 182 394 576
Breast Cancer Journey 4,827 (1,013 ) 3,814
Comfort boxes - 10,460 10,460
5,009 9,841 14,850
TOTAL FUNDS 36,633 37,239 73,872

Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

11. MOVEMENT IN FUNDS - continued

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 158,100 (130,702 ) 27,398

Restricted funds
Support delivery 9,848 (9,454 ) 394
Breast Cancer Journey 6,000 (7,013 ) (1,013 )
Comfort boxes 15,500 (5,040 ) 10,460
31,348 (21,507 ) 9,841
TOTAL FUNDS 189,448 (152,209 ) 37,239

A current year 12 months and prior year 12 months combined position is as follows:

Net
movement At
At 1.1.23 in funds 31.12.24
£    £    £   
Unrestricted funds
General fund 31,624 37,712 69,336

Restricted funds
Support delivery 182 394 576
Breast Cancer Journey 4,827 (2,033 ) 2,794
Comfort boxes - 9,158 9,158
5,009 7,519 12,528
TOTAL FUNDS 36,633 45,231 81,864

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 306,752 (269,040 ) 37,712

Restricted funds
Support delivery 19,302 (18,908 ) 394
Breast Cancer Journey 12,000 (14,033 ) (2,033 )
Comfort boxes 43,030 (33,872 ) 9,158
74,332 (66,813 ) 7,519
TOTAL FUNDS 381,084 (335,853 ) 45,231

Cancer Card

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

12. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 December 2024.